Good quality locally procured drugs can be as effective as internationally quality assured drugs in treating multi-drug resistant tuberculosis

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Qadeer, Ejaz ^a   Fatima, Razia ^a   Fielding, Katherine ^b   Qazi, Fahad ^c   Moore, David ^b   Khan, Mishal S ^b  

^a National Tuberculosis Control Program   (Pakistan)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Research Alliance for Advocacy and Development (RAAD)   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ISONIAZID; KANAMYCIN; QUINOLONE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG QUALITY; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME; ADOLESCENT; AGED; HEALTH CARE QUALITY; MIDDLE AGED; PAKISTAN; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PAKISTAN; QUALITY ASSURANCE, HEALTH CARE; RETROSPECTIVE STUDIES; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84929453108     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126099     Document Type: Article

References (13)

1. Global tuberculosis report 2013. Geneva: World Health Organization.
2. Gupta R, Brenner JG, Henry CL, Kim JY, Shin S, Espinal M, et al. (2000) Procurement of second-line anti-tuberculosis drugs for DOTS-Plus pilot projects: proceedings of a meeting, Cambridge, USA, 5-6 July 1999. Geneva: World Health Organization. 19 p. p.
3. WHO (2011) The New Global Framework to support expansion of MDR-TB services and care.
4. Gupta R, Cegielski JP, Espinal MA, Henkens M, Kim JY, Lambregts-Van Weezenbeek CS, et al. (2002) Increasing transparency in partnerships for health - introducing the Green Light Committee. Trop Med Int Health 7: 970-976. PMID: 12390604
5. Kurbatova EV, Taylor A, Gammino VM, Bayona J, Becerra M, Danilovitz M et al. (2012) Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects. Tuberculosis (Edinb) 92: 397-403. doi: 10.1016/j.tube.2012.06.003 PMID: 22789497
6. Johnston JC, Shahidi NC, Sadatsafavi M, Fitzgerald JM (2009) Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS One 4: e6914. doi: 10.1371/journal.pone.0006914 PMID: 19742330
7. Holtz TH, Sternberg M, Kammerer S, Laserson KF, Riekstina V, Zarovska E, et al. (2006) Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome. Ann Intern Med 144: 650-659. PMID: 16670134
8. Qazi F, Khan U, Khowaja S, Javaid M, Ahmed A, Salahuddin N, et al. (2011) Predictors of delayed culture conversion in patients treated for multidrug-resistant tuberculosis in Pakistan. Int J Tuberc Lung Dis 15: 1556-1559, i. doi: 10.5588/ijtld.10.0679 PMID: 22008773
9. Mpagama SG, Heysell SK, Ndusilo ND, Kumburu HH, Lekule IA, Kisonga RM, et al. (2013) Diagnosis and interim treatment outcomes from the first cohort of multidrug-resistant tuberculosis patients in Tanzania. PLoS One 8: e62034. doi: 10.1371/journal.pone.0062034 PMID: 23675411
10. Yew WW, Chan CK, Chau CH, Tam CM, Leung CC, Wong PC, et al. (2000) Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens. Chest 117: 744-751. PMID: 10713001
11. Al-Moamary MS, Black W, Bessuille E, Elwood RK, Vedal S (1999) The significance of the persistent presence of acid-fast bacilli in sputum smears in pulmonary tuberculosis. Chest 116: 726-731. PMID: 10492279
12. Lee JS, Kim EC, Joo SI, Lee SM, Yoo CG, Kim YW, et al. (2008) The incidence and clinical implication of sputum with positive acid-fast bacilli smear but negative in mycobacterial culture in a tertiary referral hospital in South Korea. J Korean Med Sci 23: 767-771. doi: 10.3346/jkms.2008.23.5.767 PMID: 18955779
13. Almuzaini T, Choonara I, Sammons H (2013) Substandard and counterfeit medicines: a systematic review of the literature. BMJ Open 3: e002923. doi: 10.1136/bmjopen-2013-002923 PMID: 23955188